je.st
news
Elan in $1 billion royalty deal with Theravance
2013-05-13 09:42:52| Biotech - Topix.net
Elan will make a once off payment of $1 billion to the company in exchange for a 21% stake in future royalty payments from four respiratory programmes which Theravance has developed with GlaxosmithKline.
Tags: with
deal
billion
royalty
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||